Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

KOVE medical AG

History from 12 Nov 2020

UID
CHE-371.219.996
Legal form
AG
Canton
ZH
Founded
12 Nov 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 193k
48k97k145k193k28 Jun 2023 · CHF 144k15 Jul 2025 · CHF 153k25 Jun 2026 · CHF 193k202420252026
  • shares

Record

  1. Company formed

    Founded 12 Nov 2020

    SHAB HR01-1005023963 ↗
  2. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    100’000 → 144’187
    Shares
    100’000 → 144’187
    New shares, % of post-step shares
    30.6% (44’187 new)

    Aktienkapital neu: CHF 144'187.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 144'187.00 [bisher: CHF 100'000.00]. Aktien neu: 144'187 Namenaktien zu CHF 1.00 [bisher: 100'000 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 20.06.2023 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005779898 ↗
  3. Capital band adopted

    SHAB HR02-1005779898 ↗
  4. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    144’187 → 153’412
    Shares
    144’187 → 153’412
    New shares, % of post-step shares
    6.0% (9’225 new)

    Aktienkapital neu: CHF 153'412.00 [bisher: CHF 144'187.00]. Liberierung Aktienkapital neu: CHF 153'412.00 [bisher: CHF 144'187.00]. Aktien neu: 153'412 Namenaktien zu CHF 1.00 [bisher: 144'187 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 24.06.2025 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen. [bisher: Die Gesellschaft hat mit Beschluss vom 20.06.2023 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006384408 ↗
  5. Capital band adopted

    SHAB HR02-1006384408 ↗
  6. Capital increase

    Likely financing

    Paid in cash and by other means

    Nominal capital
    153’412 → 193’199
    Shares
    153’412 → 193’199
    New shares, % of post-step shares
    20.6% (39’787 new)

    Aktienkapital neu: CHF 193'199.00 [bisher: CHF 153'412.00]. Liberierung Aktienkapital neu: CHF 193'199.00 [bisher: CHF 153'412.00]. Aktien neu: 193'199 Namenaktien zu CHF 1.00 [bisher: 153'412 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006687629 ↗

Published by 28 Jun 2026

Latest available record · 8 Oct 2026